Activation of amygdalar metabotropic glutamate receptors modulates anxiety, and risk assessment behaviors in ovariectomized estradiol-treated female rats

Pharmacology Biochemistry and Behavior

Volumn 101, Issue 3, 2012, Pages 369-378

  De Jesús Burgos, María ^a   Torres Llenza, Vanessa ^a   Pérez Acevedo, Nivia L ^a  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

Anxiety related behaviors; Basolateral amygdala; Estrogen; Metabotropic glutamate receptors; Ovariectomized female rats

Indexed keywords

1 AMINO 1,5 INDANDICARBOXYLIC ACID; 3,5 DIHYDROXYPHENYLGLYCINE; ESTRADIOL; ESTROGEN RECEPTOR; METABOTROPIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASOLATERAL AMYGDALA; CONTROLLED STUDY; DRUG EFFECT; EMOTION; FEAR; FEMALE; FREEZING; GENERALIZED ANXIETY DISORDER; GROOMING; LOCOMOTION; MAZE TEST; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; REARING; RISK ASSESSMENT; THREAT;

AMYGDALA; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; ESTRADIOL; FEMALE; GLYCINE; INDANS; MALE; MAZE LEARNING; OVARIECTOMY; OVARY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ESTROGEN; RECEPTORS, METABOTROPIC GLUTAMATE; RESORCINOLS;

RATTUS;

EID: 84857135672     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2012.01.016     Document Type: Article

References (86)

1. Anglada-Figueroa D, Quirk GJ. Lesions of the basal amygdala block expression of conditioned fear but not extinction. J Neurosci 2005;25:9680-5. (Pubitemid 41510908)
2. Aroniadou-Anderjaska V, Qashu F, Braga MF. Mechanisms regulating gabaergic inhibitory transmission in the basolateral amygdala: implications for epilepsy and anxiety disorders. Amino Acids 2007;32:305-15. (Pubitemid 46559582)
3. Bananej M, Karimi-Sori A, Zarrindast MR, Ahmadi S. D1 and D2 dopaminergic systems in the rat basolateral amygdala are involved in anxiogenic-like effects induced by histamine. J Psychopharmacol 2011;5:31.
4. Blanchard RJ, Yudko EB, Rodgers RJ, Blanchard DC. Defense systempsychopharmacology: an ethological approach to the pharmacology of fear and anxiety. Behav Brain Res 1993;58(1-2):155-65. (Pubitemid 24024055)
5. Blanchard DC, Griebel G, Pobbe R, Blanchard RJ. Risk assessment as an evolved threat detection and analysis process. Neurosci Biobehav Rev 2011;35(4):991-8.
6. Blurton-Jones M, Tuszynski M. Estrogen receptor-beta colocalizes extensively with parvalbumin-labeled inhibitory neurons in the cortex, amygdala, basal forebrain, and hippocampal formation of intact and ovariectomized adult rats. J Comp Neurol 2002;452(3):276-87. [21].
7. Boulware MI, Mermelstein PG. The influence of estradiol on nervous system function. Drug News Perspect 2005;18:631-7.
8. Boulware MI, Weick JP, Becklund BR, Kuo SP, Groth RD, Mermelstein PG. Estradiol activates group I and II metabotropic glutamate receptor signaling, leading to opposing influences on camp response element-binding protein. J Neurosci 2005;25:5066-78. (Pubitemid 40712851)
9. Brodkin J, Busse C, Sukoff SJ, Varney MA. Anxiolytic-like activity of the mglur5 antagonist MPEP a comparison with diazepam and buspirone. Pharmacol Biochem Behav 2002;73:359-66. (Pubitemid 34773437)
10. Burghardt PR, Wilson MA. Microinjection of naltrexone into the central, but not the basolateral, amygdala blocks the anxiolytic effects of diazepam in the plus maze. Neuropsychopharmacology 2006;31(6):1227-40. (Pubitemid 43971839)
11. Busse CS, Brodkin J,Tattersall D,Anderson JJ, Warren N, Tehrani L, et al. The behavioral profile of the potent and selective mglu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl]pyridine (MTEP) in rodent models of anxiety. Neuropsychopharmacology 2004;29:1971-9. (Pubitemid 39486548)
12. Car H, Nadlewska A, Wisniewski K. 3,5-DHPG influences behavioral effects of baclofen in rats. Pol J Pharmacol 2000;52:247-54.
13. Casarrubea M, Sorbera F, Magnusson MS, Crescimanno G. T-pattern analysis of diazepam-induced modifications on the temporal organization of rat behavioral response to anxiety in hole board. Psychopharmacology (Berl) 2011;215(1): 177-89.
14. Chojnacka-Wójcik E, Klodzinska A, Pilc A. Glutamate receptor ligands as anxiolytics. Curr Opin Investig Drugs 2001;2:1112-9. (Pubitemid 32782621)
15. Cole JC, Rodgers RJ. An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze. Behav Pharmacol 1993;4(6):573-80. (Pubitemid 24002272)
16. Cole JC, Rodgers RJ. Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol. Psychopharmacology (Berl) 1994;114(2):288-96. (Pubitemid 24152120)
17. Conn PJ, Pin JP. Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 1997;37:205-37. (Pubitemid 27238875)
18. Crawley JN. What's wrong with my mouse?: Behavioral phenotyping of transgenic and knockout mice. 2nd ed. Indianapolis: John Wiley; 2007.
19. Cruz AP, Frei F, Graeff FG. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol Biochem Behav 1994;49(1):171-6. (Pubitemid 24297273)
20. Davis M, Whalen PJ. The amygdala: vigilance and emotion. Mol Psychiatry 2001;6: 13-34. (Pubitemid 32096061)
21. Dewing P, Boulware MI, Sinchak K, Christensen A, Mermelstein PG, Micevych P. Membrane estrogen receptor-alpha interactions with metabotropic glutamate receptor 1a modulate female sexual receptivity in rats. J Neurosci 2007;27:9294-300. (Pubitemid 47358210)
22. Diaz-Veliz G, Alarcón T, Espinoza C, Dussaubat N, Mora S. Ketanserin and anxiety levels: influence of gender, estrous cycle, ovariectomy and ovarian hormones in female rats. Pharmacol Biochem Behav 1997;58:637-42. (Pubitemid 27438117)
23. Erskine MS, Kornberg E. Stress and ACTH increase circulating concentrations of 3 alpha-androstanediol in female rats. Life Sci 1992;51:2065-71.
24. Espejo EF. Selective dopamine depletion within the medial prefrontal cortex induces anxiogenic-like effects in rats placed on the elevated plus maze. Brain Res 1997;762(1-2):281-4. (Pubitemid 27315966)
25. Febo M, Jimenez-Rivera CA, Segarra AC. Estrogen and opioids interact to modulate the locomotor response to cocaine in the female rat. Brain Res 2002;943:51-61.
26. File SE. The amygdala: anxiety and benzodiazepines. The amygdala: a functional analysis. 2nd ed. Aggleton: Oxford University; 2000.
27. File SE, Gonzalez LE, Gallant R. Role of the basolateral nucleus of the amygdala in the formation of a phobia. Neuropsychopharmacology 1998;19(5):397-405. (Pubitemid 28451595)
28. Frye CA, Wawrzycki J. Effect of prenatal stress and gonadal hormone condition on depressive behaviors of female and male rats. Horm Behav 2003;44:319-26. (Pubitemid 37378211)
29. Frye CA, Petralia SM, Rhodes ME. Estrous cycle and sex differences in performance on anxiety tasks coincide with increases in hippocampal progesterone and 3alpha,5alpha-THP. Pharmacol Biochem Behav 2000;67(3):587-96. (Pubitemid 32103570)
30. Goldstein JM, Jerram M, Poldrack R, Ahern T, Kennedy DN, Seidman LJ, et al. Hormonal cycle modulates arousal circuitry in women using functional magnetic resonance imaging. J Neurosci 2005;25:9309-16. (Pubitemid 41500840)
31. Griebel G, Perrault G, Sanger DJ. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone. Psychopharmacology (Berl) 1998;138(1):55-66. (Pubitemid 28319048)
32. Griebel G, Rodgers RJ, Perrault G, Sanger DJ. The effects of compounds varying in selectivity as 5-HT(1A) receptor antagonists in three rat models of anxiety. Neuropharmacology 2000;39(10):1848-57. (Pubitemid 30398488)
33. Grove-Strawser D, Boulware MI, Mermelstein PG. Membrane estrogen receptors activate the metabotropic glutamate receptors mGluR5 and mGluR3 to bidirectionally regulate CREB phosphorylation in female rat striatal neurons. Neuroscience 2010;170(4):1045-55.
34. Hill MN, Karacabeyli ES, Gorzalka BB. Estrogen recruits the endocannabinoid system to modulate emotionality. Psychoneuroendocrinology 2007;32:350-7. (Pubitemid 46617780)
35. Holy Z, Wisniewski K. Examination of the influence of 3,5-DHPG on behavioral activity of angiotensin II. Pol J Pharmacol 2001;53:235-43.
36. Jászberényi M, Bagosi Z, Thurzó B, Földesi I, Szabó G, Telegdy G. Endocrine, behavioral and autonomic effects of neuropeptide AF. Horm Behav 2009;56(1):24-34.
37. Jorge JC, González L, Fortis A, Cruz ND. Sex-specific modulation of anxiety and locomotion after neonatal exposure to pregnenolone sulfate. Physiol Behav 2005;83(5): 779-86. [17]. (Pubitemid 40091611)
38. Kendler KSTL, Prescott CA. Gender differences in the rates of exposure to stressful life events and sensitivity to their depressogenic effects. Am J Psychiatry 2001;158:587-93. (Pubitemid 32289821)
39. Kingston AE, Griffey K, Johnson MP, Chamberlain MJ, Kelly G, Tomlinson R, et al. Inhibition of group I metabotropic glutamate receptor responses in vivo in rats by a new generation of carboxyphenylglycine-like amino acid antagonists. Neurosci Lett 2002;330(2):127-30. [20]. (Pubitemid 35257881)
40. Klodzinska A, Tatarczynska E, Stachowicz K, Chojnacka-Wojcik E. The anxiolytic-like activity of aida (1-aminoindan-1,5-dicarboxylic acid), an mGlu 1 receptor antagonist. J Physiol Pharmacol 2004;55:113-26. (Pubitemid 38524218)
41. Koss WA, Gehlert DR, Shekhar A. Different effects of subchronic doses of 17-beta estradiol in two ethologically based models of anxiety utilizing female rats. Horm Behav 2004;46:158-64. (Pubitemid 38901035)
42. Kuo J, Hariri OR, Bondar G, Ogi J, Micevych P. Membrane estrogen receptor-alpha interacts with metabotropic glutamate receptor type 1a to mobilize intracellular calcium in hypothalamic astrocytes. Endocrinology 2009;150:1369-76.
43. LeDoux J. The amygdala and emotion: a view through fear. The amygdala: a functional analysis. 2nd edition. Aggleton: Oxford University; 2003.
44. Meitzen J, Mermelstein PG. Estrogen receptors stimulate brain region specific metabotropic glutamate receptors to rapidly initiate signal transduction pathways. J Chem Neuroanat 2011;42(2):236-41.
45. Mendez P, Garcia-Segura LM, Muller D. Estradiol promotes spine growth and synapse formation without affecting pre-established networks. Hippocampus 2011;21(12): 1263-7. [Dec].
46. Mora S, Dussaubat N, Diaz-Veliz G. Effects of the estrous cycle and ovarian hormones on behavioral indices of anxiety in female rats. Psychoneuroendocrinology 1996;21:609-20. (Pubitemid 27107341)
47. Morgan MA, Pfaff DW. Estrogen's effects on activity, anxiety, and fear in two mouse strains. Behav Brain Res 2002;132:85-93. (Pubitemid 34195462)
48. Moura PJ, Petersen SL. Estradiol acts through nuclear- and membrane-initiated mechanisms to maintain a balance between GABAergic and glutamatergic signaling in the brain: implications for hormone replacement therapy. Rev Neurosci 2010;21(5):363-80.
49. Nadlewska A, Car H, Oksztel R, Wisniewski K. Effect of (s)-3,5-DHPG on learning, exploratory activity and anxiety in rats with experimental hypoxia. Pol J Pharmacol 2002;54:11-8. (Pubitemid 34269618)
50. Nair A, Vaidya VA. Cyclic AMP response element binding protein and brain-derived neurotrophic factor: molecules that modulate our mood? J Biosci 2006;31: 423-34. (Pubitemid 44411515)
51. Nomikos GG, Spyraki C. Influence of oestrogen on spontaneous and diazepam-induced exploration of rats in an elevated plus maze. Neuropharmacol 1988;27:691-6.
52. Palucha A, Pilc A. Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs. Pharmacol Ther 2007;115:116-47. (Pubitemid 46992810)
53. Paré D, Quirk GJ, LeDoux JE. New vistas on amygdala networks in conditioned fear. J Neurophysiol 2004;92:1-9. (Pubitemid 38802225)
54. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 2nd ed. New York: Academic Press; 1998.
55. Pellow S, File SE. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 1986;24(3):525-9. (Pubitemid 16145187)
56. Perez de la Mora M, Lara-Garcia D, Jacobsen KX, Vazquez-Garcia M, Crespo-Ramirez M, Flores-Gracia C, et al. Anxiolytic-like effects of the selective metabotropic glutamate receptor 5 antagonist MPEP after its intra-amygdaloid microinjection in three different non-conditioned rat models of anxiety. Eur J Neurosci 2006;23: 2749-59. (Pubitemid 43801467)
57. Pérez-Acevedo NL, Lathroum L, Jorge JC. The neurosteroid 3-alpha DIOL modulates place preference when infused in the basolateral amygdala according to sex. Behav Neurosci 2006;120:632-40. (Pubitemid 44050543)
58. Pesold C, Treit D. The central and basolateral amygdala differentially mediate the anxiolytic effects of benzodiazepines. Brain Res 1995;671:213-21.
59. Pietraszek M, Sukhanov I, Maciejak P, Szyndler J, Gravius A, Wislowska A, et al. Anxiolytic-like effects of mglu1 and mglu5 receptor antagonists in rats. Eur J Pharmacol 2005;514: 25-34. (Pubitemid 40692760)
60. Rodgers RJ, Cole JC. Anxiety enhancement in the murine elevated plus maze by immediate prior exposure to social stressors. Physiol Behav 1993;53:383-8. (Pubitemid 23048347)
61. Rodgers RJ, Davies B, Shore R. Absence of anxiolytic response to chlordiazepoxide in two common background strains exposed to the elevated plus-maze: importance and implications of behavioural baseline. Genes Brain Behav 2002;1(4):242-51. (Pubitemid 36717670)
62. Rodgers RJ, Howard K, Stewart S, Waring P, Wright FL. Anxioselective profile of glycineB receptor partial agonist, D-cycloserine, in plus-maze-naïve but not plus-maze-experienced mice. Eur J Pharmacol 2010;646(1-3):31-7.
63. Rodgers RJ, Harvest H, Hassall C, Kaddour LA. D-cycloserine enhances memory consolidation in the plus-maze retest paradigm. Behav Neurosci 2011;125(1):106-16.
64. Rogel-Salazar G, López-Rubalcava C. Evaluation of the anxiolytic-like effects of clomipramine in two rat strains with different anxiety vulnerability (Wistar and Wistar-Kyoto rats): participation of 5-HT1A receptors. Behav Pharmacol 2011;22(2):136-46.
65. Rojas-Ortiz YA, Rundle-González V, Rivera-Ramos I, Jorge JC. Modulation of elevated plus maze behavior after chronic exposure to the anabolic steroid 17alpha-methyltestosterone in adult mice. Horm Behav 2006;49(1):123-8. (Pubitemid 41821877)
66. Romano C, Sesma MA, McDonald CT, O'Malley K, Van den Pol AN, Olney JW. Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J Comp Neurol 1995;355(3):455-69.
67. Rudy JW, Matus-Amat P. DHPG activation of group 1 mGluRs in BLA enhances fear conditioning. Learn Mem 2009;16(7):421-5.
68. Sah P, Faber ES, Lopez De Armentia M, Power J. The amygdaloid complex: anatomy and physiology. Physiol Rev 2003;83:803-34. (Pubitemid 36828926)
69. Sierra-Mercado D, Padilla-Coreano N, Quirk GJ. Dissociable roles of prelimbic and infralimbic cortices, ventral hippocampus, and basolateral amygdala in the expression and extinction of conditioned fear. Neuropsychopharmacology 2011;36(2):529-38.
70. Spooren WP, Vassout A, Neijt HC, Kuhn R, Gasparini F, Roux S, et al. Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents. J Pharmacol Exp Ther 2000;295: 1267-75.
71. Spooren W, Lasege A, Lavreysen H, Gasparini F, Steckler T. Metabotropic glutamate receptors: their therapeutic potential in anxiety. Curr Top Behav Neurosci 2010;2:391-413.
72. Steckler T, Lavreysen H, Oliveira AM, Aerts N, Van Craenendonck H, Prickaerts J, et al. Effects of mGlu1 receptor blockade on anxiety-related behaviour in the rat lick suppression test. Psychopharmacology (Berl) 2005;179:198-206. (Pubitemid 40576707)
73. Tangen T, Mykletun A. Depression and anxiety through the climacteric period: an epidemiological study (HUNT-II). J Psychosom Obstet Gynaecol 2008;29(2): 125-31. (Pubitemid 351873842)
74. Tatarczynska EKA, Kroczka B, Chojnacka-Wójcik E, Pilc A. The antianxiety-like effects of antagonists of group I and agonists of group II and III metabotropic glutamate receptors after intrahippocampal administration. Psychopharmacology (Berl) 2001;158:94-9.
75. Tye KM, Prakash R, Kim SY, Fenno LE, Grosenick L, Zarabi H, et al. Amygdala circuitry mediating reversible and bidirectional control of anxiety. Nature 2011;471(7338): 358-62.
76. Vaglenova J, Parameshwaran K, Suppiramaniam V, Breese CR, Pandiella N, Birru S. Long-lasting teratogenic effects of nicotine on cognition: gender specificity and role of AMPA receptor function. Neurobiol Learn Mem 2008;90:527-36.
77. Vazdarjanova A, McGaugh JL. Basolateral amygdala is involved in modulating consolidation of memory for classical fear conditioning. J Neurosci 1999;19:6615-22. (Pubitemid 29347460)
78. Vianna MR, Coitinho AS, Izquierdo I. Role of the hippocampus and amygdala in the extinction of fear-motivated learning. Curr Neurovasc Res 2004;1(1):55-60.
79. Walf AA, Frye CA. Antianxiety and antidepressive behavior produced by physiological estradiol regimen may be modulated by hypothalamic-pituitary- adrenal axis activity. Neuropsychopharmacology 2005;30:1288-301.
80. Walf AA, Frye CA. A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior. Neuropsychopharmacology 2006;31:1097-111. (Pubitemid 43971828)
81. Walf AA, Frye CA. Parity and estrogen-administration alter affective behavior of ovariectomized rats. Physiol Behav 2008;93(1-2):351-6.
82. Walf AA, Frye CA. Raloxifene and/or estradiol decrease anxiety-like and depressive-like behavior, whereas only estradiol increases carcinogen-induced tumorigenesis and uterine proliferation among ovariectomized rats. Behav Pharmacol 2010;21(3):231-40.
83. Wilson MA. GABA physiology: modulation by benzodiazepines and hormones. Crit Rev Neurobiol 1996;10(1):1-37. (Pubitemid 26283953)
84. Wilson MA, Biscardi R. Influence of gender and brain region on neurosteroid modulation of GABA responses in rats. Life Sciences 1997;19:1679-91. (Pubitemid 27210122)
85. Xiang X, Huang W, Haile CN, Kosten TA. Hippocampal GluR1 associates with behavior in the elevated plus maze and shows sex differences. Brain Res 2011;222(2):326-31.
86. Zuena AR, Mairesse J, Casolini P, Cinque C, Alemà GS, Morley-Fletcher S, et al. Prenatal restraint stress generates two distinct behavioral and neurochemical profiles in male and female rats. PLoS One 2008;3(5):e2170. [May 14].